Safeena Khan

Safeena Khan

Auto-generated profile, based on publicly available information

Safeena Khan

Department of Medicine, Khyber Medical College, Peshawar, Pakistan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2025 in Therapeutic Advances in Hematology
Verified
Journal Article
Open access
MOMuhammad Osama
Muhammad Osama
MKMuhammad Haris Khan
Muhammad Haris Khan
SKSafeena Khan
Safeena Khan
AHAmna Hussain
Amna Hussain
ATAmmara Tahir
Ammara Tahir
WRWajeeh Ur Rehman
Wajeeh Ur Rehman
Background: Anti-CD38 monoclonal antibodies (mAbs) have significantly changed the multiple myeloma treatment landscape. This meta-analysis compared the efficacy and safety of anti-CD38 mAb-based therapy versus standard therapy in newly diagnosed multiple myeloma (NDMM) patients. Methods: We performed a comprehensive literature search on PubMed, the Cochrane Database, and ClinicalTrials.gov. The primary outcomes were progression-free survival (PFS) and minimal residual disease (MRD) status. Dichotomous outcomes were pooled using risk ratio (RR) along with the 95% confidence interval (CI) in RevMan 5.4. Subgroup analysis and meta-regression analysis were performed. The RoB 2.0 tool was used to assess the risk of bias. Results: Our meta-analysis included 11 randomized controlled trials. There were 5270 patients; 3040 TEs and 2230 TIEs. Anti-CD38 mAbs significantly improved MRD negativity (RR 1.94, 95% CI: 1.59–2.37; p < 0.00001) and PFS (RR 0.51, 95% CI: 0.45–0.58; p < 0.00001). Subgroup analyses revealed better outcomes for both the TE (MRD: RR 1.52, 95% CI: 1.37–1.68; PFS: RR 0.43, 95% CI: 0.34–0.54) and TIE (MRD: RR 3.49, 95% CI: 2.65–4.61; PFS: RR 0.55, 95% CI: 0.47–0.64) populations. Meta-regression revealed that Eastern Cooperative Oncology Group (ECOG) score 0 significantly influenced MRD status (β = −0.015, p < 0.05), whereas ECOG scores 1 and 2 lacked statistical significance. Subgroup analysis revealed that PFS was significantly different between standard (RR 0.47) and high (RR 0.81) cytogenetic risk groups. Conclusion: In NDMM patients, anti-CD38 mAb-based therapy significantly improved MRD status, and PFS compared with standard therapy alone, in both TE and TIE patients, suggesting a favorable benefit–risk profile.

7 February 2025 in Journal of International Medical Research
Verified
Journal Article
Open access
MKMalik Waleed Zeb Khan
Malik Waleed Zeb Khan
AAAizaz Ali
Aizaz Ali
AHAmna Hussain
Amna Hussain
SKSafeena Khan
Safeena Khan
ATAmmara Tahir
Ammara Tahir
JIJibran Ikram
Jibran Ikram
Objective: To investigate the safety and efficacy of laquinimod in treating relapsing-remitting multiple sclerosis (RRMS). Methods: An extensive electronic search was conducted across PubMed, Embase, Cochrane Database of Systematic Reviews, and ClinicalTrials.gov to identify suitable studies. Risk of bias was assessed using Cochrane’s Risk of Bias tool. Statistical analysis was performed using RevMan 5.4.1. Results: The meta-analysis of four randomized controlled trials including 3665 patients found that laquinimod significantly reduced the annualized relapse rate compared with placebo (mean difference = −0.08, 95% confidence interval [CI] = −0.12, −0.04, I2 = 0%). For disability progression confirmed at 3 months, laquinimod provided a significant advantage over placebo (hazard ratio [HR] = 0.75, 95% CI = 0.59, 0.96, I2 = 25%), whereas no benefit was achieved at 6 months (HR = 0.69, 95% CI = 0.45, 1.06, I2 = 66%). Laquinimod was also significantly better than placebo in maintaining a relapse-free status (risk ratio [RR] = 1.14 95% CI = 1.06, 1.22, I2 = 10%). Laquinimod had a comparable safety profile as placebo (RR = 1.06, 95% CI = 0.81, 1.39, I2 = 33%). Conclusions: These findings support the efficacy of laquinimod in managing RRMS but necessitate careful monitoring during treatment.

1 January 2025 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
MKMomin Khan
Momin Khan
SKSafeena Khan
Safeena Khan
MKMuhammad Haris Khan
Muhammad Haris Khan
UTUmar Tariq
Umar Tariq
WRWajeeh Ur Rehman
Wajeeh Ur Rehman
Bacterial and fungal infections are recognized as prevalent etiological factors contributing to the symptoms associated with urinary tract infections and vulvovaginitis, respectively. This report presents a notable instance of a nonbacterial cause, specifically involving Enterobius vermicularis (pinworm). A 7‐year‐old female patient from a low socioeconomic background is reported, presenting with a 14‐month history of recurrent urinary symptoms and vulvovaginitis. This clinical picture persists despite multiple courses of antibiotic therapy and negative urinary cultures. The diagnosis was established following meticulous urine collection, which demonstrated the presence of motile organisms identified as Enterobius vermicularis . The patient exhibited a favorable response to the administered treatment. This case highlights the importance of considering parasitic infections in the differential diagnosis of recurrent urinary symptoms, especially in pediatric patients with inadequate hygiene and lower socioeconomic conditions.

30 July 2024 in medtigo Journal of Medicine
Verified
Journal Article
Open access
SKSafeena Khan
Safeena Khan
SISehba Iqbal
Sehba Iqbal
SOSyed Mohammad Omair
Syed Mohammad Omair
AJArshmaan Jawad
Arshmaan Jawad
WIWaqas Inayat
Waqas Inayat
IHIqbal Haider
Iqbal Haider
Learn about the distinctive MRI findings associated with CSVD and the importance of blood pressure management for prevention.

30 October 2025 in medtigo Journal of Medicine
Verified
Journal Article
Open access
SFSudais Fazal
Sudais Fazal
ARAbdullah Rahat
Abdullah Rahat
FRFarhan Riaz
Farhan Riaz
SKSafeena Khan
Safeena Khan
ARAbdul Rehman
Abdul Rehman

9 September 2026 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
JIJunaid Imran
Junaid Imran
MRMohammad Zohaib Rehman
Mohammad Zohaib Rehman
MOMuhammad Osama
Muhammad Osama
SKSafeena Khan
Safeena Khan
PTPawan Kumar Thada
Pawan Kumar Thada
Takayasu arteritis should be suspected in young females with limb claudication, absent pulses, recurrent arterial stenosis, and elevated inflammatory markers. Early diagnosis is crucial to prevent complications. In G6PD‐deficient females, treatment must be modified, as specific immunosuppressants, like cyclophosphamide, can induce hemolysis. Accurate diagnosis ensures effective management.